WallStreetZenWallStreetZen

NASDAQ: ENSC
Ensysce Biosciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ensysce Biosciences revenue was $0.00 for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ENSC annual revenue was $0.0, with N/A growth year-over-year.

ENSC revenue history

Current Revenue
$0.0
Current Earnings
-$6.6M
Current Profit Margin
0%

Be the first to know when ENSC announces revenue.

ENSC Revenue History By Year

ENSC Yearly RevenueENSC RevenueENSC ChangeENSC Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A

1 of 1

Ensysce Biosciences Revenue FAQ

What was ENSC's revenue last quarter?

Ensysce Biosciences (NASDAQ: ENSC) reported Q2 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Ensysce Biosciences's revenue was $0.00.

What was Ensysce Biosciences's revenue in 2024?

Ensysce Biosciences's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Ensysce Biosciences make in a day?

Based on Ensysce Biosciences annual revenue for the past five years, ENSC makes an average of $0.00 per day.

What was Ensysce Biosciences's annual revenue growth in the past year?

As of Q4 2025, Ensysce Biosciences's revenue has grown null year over year. Ensysce Biosciences's revenue in the past year totaled $0.00.

How much does Ensysce Biosciences make in a year?

Ensysce Biosciences's revenue by year for the past five years is:
  • Ensysce Biosciences's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Ensysce Biosciences's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Ensysce Biosciences's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Ensysce Biosciences's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Ensysce Biosciences's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.